US equities
|
NVDA
$150.79
▼-3.00%
MU
$697.78
▼-2.05%
AMD
$522.72
▲+3.84%
SPCX
$143.84
▲+1.51%
SNDK
$771.11
▼-3.28%
AMZN
$266.62
▲+3.39%
TSLA
$383.87
▲+0.99%
AAPL
$352.33
▲+0.12%
NVDA
$150.79
▼-3.00%
MU
$697.78
▼-2.05%
AMD
$522.72
▲+3.84%
SPCX
$143.84
▲+1.51%
SNDK
$771.11
▼-3.28%
AMZN
$266.62
▲+3.39%
TSLA
$383.87
▲+0.99%
AAPL
$352.33
▲+0.12%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about CT/4201
Recent news which mentions CT/4201
FDA Endorses CaaMTech's Psilocin Drug Development For Depression Treatment
November 14, 2024
Tickers
CMPS
NEWS
Tags
Psychedelic Therapy
drug trials
CaaMTech Inc/
From
Benzinga